Literature DB >> 27094713

Interleukin-6 influences stress-signalling by reducing the expression of the mTOR-inhibitor REDD1 in a STAT3-dependent manner.

Jessica Pinno1, Hannes Bongartz2, Oliver Klepsch3, Nicole Wundrack4, Valeria Poli5, Fred Schaper6, Anna Dittrich7.   

Abstract

Interleukin 6 (IL-6) is a pleiotropic cytokine and a strong activator of Mammalian Target of Rapamycin (mTOR). In contrast, mTOR activity is negatively regulated by Regulated in Development and DNA Damage Responses 1 (REDD1). Expression of REDD1 is induced by cellular stressors such as glucocorticoids and DNA damaging agents. We show that the expression of basal as well as stress-induced REDD1 is reduced by IL-6. The reduction of REDD1 expression by IL-6 is independent of proteasomal or caspase-mediated degradation of REDD1 protein. Instead, induction of REDD1 mRNA is reduced by IL-6. The regulation of REDD1 expression by IL-6 is independent of Phosphatidylinositide-3-Kinase (PI3K) and Mitogen-Activated Protein Kinase (MAPK) signalling but depends on the expression and activation of Signal Transducer and Activator of Transcription 3 (STAT3). Furthermore, the reduction of basal REDD1 expression by IL-6 correlates with IL-6-induced activation of mTOR signalling. Inhibition of STAT3 activation blocks IL-6-induced mTOR activation. In summary, we present a novel STAT3-dependent mechanism of both IL-6-induced activation of mTOR and IL-6-dependent reversion of stress-induced inhibition of mTOR activity.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Interleukin 6; REDD1; STAT3; Stress signalling; mTOR

Mesh:

Substances:

Year:  2016        PMID: 27094713     DOI: 10.1016/j.cellsig.2016.04.004

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  14 in total

1.  Expression of Programmed Death Ligand 1 Is Associated with the Prognosis of Intrahepatic Cholangiocarcinoma.

Authors:  Zhitao Dong; Boyi Liao; Weifeng Shen; Chengjun Sui; Jiamei Yang
Journal:  Dig Dis Sci       Date:  2019-08-13       Impact factor: 3.199

2.  NEDD8-Activating Enzyme Inhibitor MLN4924 Inhibits Both the Tumor Stroma and Angiogenesis in Pancreatic Cancer via Gli1 and REDD1.

Authors:  Weilin Mao; Lei Zhang; Yefei Rong; Tiantao Kuang; Dansong Wang; Xuefeng Xu; Wenhui Lou; Jianang Li
Journal:  Dig Dis Sci       Date:  2022-09-13       Impact factor: 3.487

3.  Rapamycin-Sensitive Late-LTP is Enhanced in the Hippocampus of IL-6 Transgenic Mice.

Authors:  Anneke Olde Engberink; Ruben Hernandez; Pierre de Graan; Donna L Gruol
Journal:  Neuroscience       Date:  2017-11-10       Impact factor: 3.590

4.  Fibroblast-tumor cell signaling limits HER2 kinase therapy response via activation of MTOR and antiapoptotic pathways.

Authors:  Ioannis K Zervantonakis; Matthew D Poskus; Alexis L Scott; Laura M Selfors; Jia-Ren Lin; Deborah A Dillon; Shailja Pathania; Peter K Sorger; Gordon B Mills; Joan S Brugge
Journal:  Proc Natl Acad Sci U S A       Date:  2020-06-29       Impact factor: 11.205

5.  Robustness and Information Transfer within IL-6-induced JAK/STAT Signalling.

Authors:  Ulrike Billing; Tomasz Jetka; Lukas Nortmann; Nicole Wundrack; Michal Komorowski; Steffen Waldherr; Fred Schaper; Anna Dittrich
Journal:  Commun Biol       Date:  2019-01-18

6.  Hypoxia decreases macrophage glycolysis and M1 percentage by targeting microRNA-30c and mTOR in human gastric cancer.

Authors:  Yun Zhihua; Tan Yulin; Wang Yibo; Ding Wei; Chu Yin; Xu Jiahao; Jiang Runqiu; Xu Xuezhong
Journal:  Cancer Sci       Date:  2019-07-12       Impact factor: 6.716

7.  Defects in mTORC1 Network and mTORC1-STAT3 Pathway Crosstalk Contributes to Non-inflammatory Hepatocellular Carcinoma.

Authors:  Ting Li; Guohong Zhang; Linlin Wang; Susu Li; Xiaoping Xu; Yi Gao
Journal:  Front Cell Dev Biol       Date:  2020-04-07

8.  DDIT4 Licenses Only Healthy Cells to Proliferate During Injury-induced Metaplasia.

Authors:  Zhi-Feng Miao; Jing-Xu Sun; Mahliyah Adkins-Threats; Min-Jiao Pang; Jun-Hua Zhao; Xin Wang; Kai-Wen Tang; Zhen-Ning Wang; Jason C Mills
Journal:  Gastroenterology       Date:  2020-09-19       Impact factor: 22.682

9.  Dysregulation in Akt/mTOR/HIF-1 signaling identified by proteo-transcriptomics of SARS-CoV-2 infected cells.

Authors:  Sofia Appelberg; Soham Gupta; Sara Svensson Akusjärvi; Anoop T Ambikan; Flora Mikaeloff; Elisa Saccon; Ákos Végvári; Rui Benfeitas; Maike Sperk; Marie Ståhlberg; Shuba Krishnan; Kamal Singh; Josef M Penninger; Ali Mirazimi; Ujjwal Neogi
Journal:  Emerg Microbes Infect       Date:  2020-12       Impact factor: 7.163

Review 10.  COVID-19 and diabetes mellitus: how one pandemic worsens the other.

Authors:  William S Azar; Rachel Njeim; Angie H Fares; Nadim S Azar; Sami T Azar; Mazen El Sayed; Assaad A Eid
Journal:  Rev Endocr Metab Disord       Date:  2020-12       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.